baber/WOPTO huggingface dataset:
Patent NZ-529847-A (NZ)
Title: Spinal cord removal tool with adjustable blades
Inventor: GWYTHER PETER
IPC: A61B17/3205
Filed: 2002-06-17
Abstract: Disclosed is a spinal cord removal tool for removing a spinal cord and spinal cord membrane from a carcass which includes a spinning blade disk (26) having multiple removal blades (40) mounted around its perimeter, each removal blade (40) having a forward facing cutting edge that can enter the spinal cord channel and side culling edges that cooperate with side blades (58) to chop the spinal cord membrane as it is brought into the tool. The side blades (58) are adjustably mounted to move towards and away from the removal blades (40) and compensate for changes in the width of the removal blades (40) due to wear or sharpening. The side blades (58) are on a manually adjustable mount that can be set to any desired blade clearance for higher-speed and lower noise operation.
Patent NZ-531956-A (NZ)
Title: Growing xenotransplant material in culture
Inventor: GARKAVENKO OLGA
Filed: 2002-09-27
Abstract: Disclosed are methods of long-term in vitro assembly, propagation and maturation of a functional artificial tissue comprised of at least two types of mammalian cells, where at least one cell type is a secretory cell and at least one type of cell is capable of providing supportive function. Also disclosed are the implementation of such artificial tissues containing secretory islet of Langerhans cells for the treatment of diabetes.
Patent NZ-532019-A (NZ)
Title: Anti-influenza drugs
Inventor: KIDO HIROSHI
IPC: A61P43/00
Filed: 2002-09-03
Abstract: Disclosed herein is a use of a composition comprising ambroxol, bromhexin or a pharmaceutically acceptable salt thereof in the manufacture of a medicament to treat influenza virus-infectious diseases, wherein the composition shows its anti-influenzal function through promoting the secretion of a bio-factor showing anti-viral function against influenza viruses and contained in a liquid secreted from the respiratory tract. These drug compositions are characterized by inhibiting the growth of an influenza virus in the airway by promoting the secretion of an inhibitor for a protease in the airway which induces the infectivity of the influenza virus. These drugs are also characterized by inhibiting the growth of an influenza virus in the airway by promoting the secretion of mucosal immunity substances IgA and IgG. These drugs are further characterized by inhibiting the release of inflammatory cytokines in the airway.
Patent NZ-538046-A (NZ)
Title: Pyrrolidone derivatives as maob inhibitors
Inventor: IDING HANS
IPC: C07D207/273
Filed: 2003-09-18
Abstract: Disclosed are compounds of the formula I and processes of preparing them wherein: Q is =N- or =C(R24)-; X-Y is -CH2-CH2-, -CH=CH- or -CH2-O- ; R1, R1.1 and R1.2 independently from each other are selected from the group consisting of hydrogen, halogen, halogen-(C1-C6)-alkyl, cyano, (C1-C6)-alkoxy or halogen-(C1-C6)-alkoxy; R21, R22 and R23 independently from each other are selected from the group consisting of hydrogen and halogen; R24 is hydrogen, halogen or methyl; R3 is -NHR6; R4 is hydrogen; and R6 is -C(O)H, -C(O)-(C1-C3)-alkyl, C(O)-halogen-(C1-C3)alkyl, -C(O)O(C1-C3)-alkyl, -C(O)NH2 or -SO2-(C1-C3)-alkyl; as well as individual isomers, racemic or non-racemic mixtures thereof. Pyrrolidone derivatives of the type disclosed are monoamine oxidase B inhibitors useful in the treatment of diseases such as Alzheimer's disease and senile dementia.
Patent NZ-545836-A (NZ)
Title: Fused heterocyclic compounds as serotonin receptor modulators
Inventor: CHAI WENYING
IPC: A61K31/4745
Filed: 2004-09-15
Abstract: Disclosed is a compound having serotonin receptor modulating activity of formula (II) wherein m is 1 or 2; p is 1 or 2, with the proviso that where m is 1, p is not 1; q is 0 or 1; r is 0, 1, 2, 3, 4, or 5; wherein the rest of the substituents are disclosed within the specification and enantiomers, diastereomers, hydrates, solvates and pharmaceutically acceptable salts, esters and amides thereof. Also disclosed is the use of the above compound in the manufacture of a medicament for the treatment or prevention of a CNS disorder. Also disclosed are methods of making the above compound.
Patent NZ-552201-A (NZ)
Title: Knitted glove with controlled stitch stretch capability
Inventor: HARDEE FRED
IPC: A41D19/00
Filed: 2005-07-14
Abstract: A knitted glove and a method for its manufacture are disclosed. The glove includes a plurality of finger components, each with at least two separate knitted sections, a thumb component with at least two separate knitted sections, a palm component with at least two separate knitted sections and a wrist component with at least one knitted section. At least one of the knitted sections comprises three different stitch dimensions.
Patent NZ-554235-A (NZ)
Title: Pillow packaging bag and pillow type packaged body
Inventor: IIZUKA KATSUJI
IPC: B65D33/18
Filed: 2005-09-27
Abstract: Disclosed is a pillow packaging bag and a pillow type packaged body formed from a continuous cylindrical film. The packaging bag is formed by two lateral seals positioned roughly parallel with each other and a contents filling part held by the two lateral seal parts. Each lateral seal has a plurality of liner portions extending in the lateral direction. Some of these linear portions are first linear portions extending over the full width of the film, others are second linear portions which extend from the center only part of the way to the edge. The second portions are positioned closer to the content-filled region than the first portions.
Patent NZ-555095-A (NZ)
Title: Process for the synthesis of 4-(3-sulfonylphenyl)-piperidines
Inventor: DESMOND RICHARD
IPC: C07D211/24
Filed: 2005-10-13
Abstract: Disclosed is a process for preparing compounds of formula VI, 4-(3-sulfonylphenyl)-piperidines and pharmaceutically acceptable salts thereof which comprises oxidizing a sulphide of the formula VIII to give a compound of formula X, followed by dehydration of the compound of formula X to give a compound of formula IX, followed by catalytic reduction of the compound of formula IX to give the compound of the formula VI, wherein the substituents are as defined in the specification.
Patent NZ-562691-A (NZ)
Title: Method for distributing a myoglobin-containing food product
Inventor: SIEGEL DAN G
Filed: 2007-10-19
Abstract: Disclosed is a method for distributing a myoglobin-containing fresh meat food product having a water content of at least 5 percent by weight and a sodium chloride content of less than 1 percent by weight comprising the steps of a) dividing the food product into a plurality of retail sized portions; b) packaging a retail-sized portion in a food packaging article comprising a transparent portion with an interior surface wherein at least a portion of the transparent portion of the interior surface is in contact with at least a portion of a surface of the food product; c) shipping the packaged retail-sized portion to a retail outlet; and d) displaying the packaged retail-sized portion on a shelf at the retail outlet, wherein a desirable appearance of the surface of the food product is visible through the transparent portion of the food packaging article and is maintained for at least a 5-day display life in the absence of a gas added to the packaged retail-sized portion, and wherein the food packaging article comprises a myoglobin blooming agent.
Patent NZ-564061-A (NZ)
Title: Benzothiazol-2-one derivatives as lipase and phospholipase inhibitors
Inventor: ZOLLER GERHARD
IPC: A61K31/428
Filed: 2006-05-27
Abstract: Disclosed are 2-oxobenzothiazol-3-carboxamide derivatives as represented by the general formula I, also including their tautomeric forms and the physiologically tolerated salts thereof, wherein the meanings of the substituents are: R1 is alkyl, alkylene-aryl, alkylene-cycloalkyl or a bicyclic moiety, where the aryl, cycloalkyl or the bicyclic moiety may be further substituted as described herein; R2 is hydrogen; R3 is hydrogen; and wherein the other substituent are as defined herein. Also disclosed is the use of a compound as defined above for producing a medicament for the treatment and/or prevention of disorders in which insulin resistance Is involved, diabetes mellitus, dyslipidemias, conditions associated with the metabolic syndrome, conditions associated with reduced HDL level and atherosclerotic disorders.
Patent NZ-568715-A (NZ)
Title: Macrocyclic factor VIIA inhibitors useful as unticoagulants
Inventor: CHENEY DANIEL L
IPC: A61K31/4709
Filed: 2006-12-21
Abstract: Disclosed are phenyl and pyridinyl macrocyclic amide derivatives as represented by the general formula (I), wherein ring A is phenyl or a pyridyl isomer defined by replacing one of CR1, CR2, CR3, or CR4 in ring A with N; ring B is phenyl or a pyridyl isomer defined by replacing one of CR8, CR9, CR10, or CR11 in ring B with N; Z is NH, O or S; W is a monocyclic or bicyclic aryl moiety optionally substituted with R14; and wherein the other substituents are as defined herein. Also disclosed is the use of a compound as defined above for the manufacture of a medicament for the treatment of a thromboembolic disorder (and specifically conditions such as unstable angina, an acute coronary syndrome, atrial fibrillation, first myocardial infarction, recurrent myocardial infarction, ischemic sudden death, transient ischemic attack, stroke, atherosclerosis, peripheral occlusive arterial disease, venous thrombosis, deep vein thrombosis, thrombophlebitis, arterial embolism, coronary arterial thrombosis, cerebral arterial thrombosis, cerebral embolism, kidney embolism, pulmonary embolism, and thrombosis resulting from medical implants, devices, or procedures in which blood is exposed to an artificial surface that promotes thrombosis).
Patent NZ-573060-A (NZ)
Title: Modulators of pharmacokinetic properties of therapeutics
Inventor: DESAI MANOJ C
IPC: A61P31/12
Filed: 2007-07-06
Abstract: Disclosed is the compound 3-((S)-1-((2R,5R)-5-(2-thiazol-5-ylacetamido)-1,6-diphenylhexan-2-ylcarbamoyl)-3-morpholinopropyl)-1-((2-isopropylthiazol-4-yl)methyl)-1-methylurea and its derivatives, optionally in the form of their pharmaceutically acceptable salts and/or solvates thereof. Further disclosed is a pharmaceutical composition which comprises the above compound and a pharmaceutically acceptable carrier or excipient; wherein the composition may further comprise one or more additional active agents. Further disclosed is the use of the above compound for the preparation of a medicament, for administration to a patient to improve the pharmacokinetics of a drug which is metabolized by cytochrome P450 monooxygenase.
Patent NZ-585369-A (NZ)
Title: Computer-implemented biological sequence identifier system and method
Inventor: MALANOSKI ANTHONY P
IPC: C12M1/34
Filed: 2006-06-09
Abstract: A method and an apparatus of reporting a taxonomic identification of a pathogen are disclosed. The method of reporting a taxonomic identification of a pathogen comprises submitting a plurality of biological sequences in queries to a taxonomic database to produce a plurality of taxonomic results. The biological sequences are the output of genetic database queries that return a score for each sequence. The method further comprises determining whether the taxonomic results contain only a single taxon; determining whether the highest score among the plurality of biological sequences exceeds the score of the biological sequence having the second highest score by a predetermined score ratio threshold; determining whether all the taxonomic results contain only a child taxon and a direct parent taxon to the child taxon; and reporting a taxonomic identification based on the taxonomic results. The reporting the taxonomic identification uses one of the following criteria-based steps and the choice of step being the first step wherein the criterion is satisfied: reporting a single taxon when the taxonomic results contain only the single taxon; reporting the taxonomic result of the biological sequence having the highest score among the plurality of sequences when the highest score exceeds the score of the biological sequence having the second highest score by a predetermined score ratio threshold; reporting a child taxon when all the taxonomic results contain only the child taxon and a direct parent taxon to the child taxon; and reporting a common parent taxon in all other cases. The method is performed using a suitably programmed computer.
Patent NZ-590529-A (NZ)
Title: A light directing device with a reflector shield positioned within a void on the non preferential side of a lens
Inventor: WILCOX KURT S
IPC: F21V1/00
Filed: 2009-06-30
Abstract: 590529 A light-directing apparatus for off-axial preferential-side distribution of light from a light emitter having an emitter axis. The apparatus includes a lens and a shield member. The lens is positioned over the light emitter and has an inner surface which defines an emitter void and a shield-receiving void. The shield receiving void is on a non-preferential side of the lens member. The shield receiving void is different in configuration than the emitter void. The lens also has an outer surface. The shield member is positioned in the shield-receiving void of the lens in the path of light emitted toward a non-preferential side of the lens.
Patent NZ-593563-A (NZ)
Title: A carrier for growing seaweed in water, the carrier comprising a sheet embedded with spores or seeds and elements for suspension in a body of water
Inventor: BAKKEN PAAL ANDREAS
IPC: A01G33/00
Filed: 2009-12-23
Abstract: 593563 A carrier (11) for growing seaweed (18) in a body of water is disclosed. The carrier is a sheet with a surface structure that will retain spores and seeds. The sheet is provided with apertures (12) which allow the flow of water from one side to the other. The sheet also comprises a rim (14, 15) arranged on at least one side thereof, suitable for receiving a rope, or a reinforcement in a middle section of the carrier or a reinforcement in the form of an integrated net. The carrier further comprises suspension elements (16, 17) for suspension in a body of water.
Patent NZ-593652-A (NZ)
Title: Two-part code to determine data associated with the code
Inventor: PINCHEN STEPHEN PAUL
IPC: G06K19/06
Filed: 2006-10-03
Abstract: A method of looking up a code in a database to determine data associated with the code. The code comprises first and second parts (F and S) and the first part (F) carries no information at the time of its creation and is associated with data in the database and is one of a set N of such first parts, and the second part (S) is related to the first part and is one of a set n of such second parts, N being greater than n. The method comprises looking up in the database the second part (S) of the code among the population n, and then looking up the first part (F) of the code within the subset N/n of first parts which share the same second part (S).
Patent NZ-601538-A (NZ)
Title: Vaccine compositions comprising a mutated factor h binding protein
Inventor: EXLEY RACHEL
IPC: A61K39/095
Filed: 2009-10-26
Abstract: Patent No. 601538 Disclosed is an immunogenic composition for use in the treatment or prevention of infection or disease caused by N. meningitidis and/or Neisseria gonorrhoeae, comprising at least one modified factor H binding protein, wherein the composition is capable of eliciting an immune response, when administered to a human or non-human animal, wherein the modified factor H binding protein has at least 70% sequence identity with the sequence MPSEPPFGRHLIFASLTCLIDAVCKKRYHNQNVYILSILRMTRSKPVNRTAFCCLSLTTALILT ACSSGGGGVAADIGAGLADALTAPLDHKDKGLQSLTLDQSVRKNEKLKLAAQGAEKTYGN GDSLNTGKLKNDKVSRFDFIRQIEVDGQLITLESGEFQVYKQSHSALTAFQTEQIQDSEHSG KMVAKRQFRIGDIAGEHTSFDKLPEGGRATYRGTAFGSDDAGGKLTYTIDFAAKQGNGKIE HLKSPELNVDLAAADIKPDGKRHAVISGSVLYNQAEKGSYSLGIFGGKAQEVAGSAEVKTVN GIRHIGLAAKQ, and has a changed amino acid at at least one position which results in no factor H binding, or significantly reduced factor H binding compared with the factor H binding protein of said sequence, wherein the at least one position is selected from the group comprising amino acid residue at position number 103, 106, 107, 108, 109, 145, 147, 149, 150, 154, 156, 157, 180, 181, 182, 183, 184, 185, 191, 193, 194, 195, 196, 199, 262, 264, 266, 267, 268, 272, 274, 283, 285, 286, 288, 289, 302, 304 306, 311 and 313 as defined in said sequence.
Patent NZ-602664-A (NZ)
Title: Pinned Connections
Inventor: MCCLANAHAN ROBERT
IPC: E02F3/58
Filed: 2008-11-18
Abstract: A pinned connection is disclosed comprising a first connection element (150) including a pair of spaced arms (153), a second connection element (160) received between the arms and a pin (230). Each arm (153) defines an aperture (151) such that the apertures are aligned with each other and each said aperture (151) has a tapered wall portion. A hole in the second connection element (160) is aligned with the apertures (151) and the pin (230) extends into the apertures (151) and the hole. A retainer (210) is located within each aperture (151) including a tapered wall portion corresponding to and engaged with the tapered wall portion of the respective aperture (151). The tapered wall portions of the apertures (151) and the retainers (210) include engaged helical projections and helical grooves to secure the retainers to the apertures.
Patent NZ-605352-A (NZ)
Title: Process for producing glycosaminoglycans
Inventor: CHOI HOO-KYUN
IPC: A61K9/70
Filed: 2009-07-15
Abstract: The present invention provides a transdermal drug delivery system comprising a drug-containing matrix layer comprising: (a) donepezil or a pharmaceutically acceptable salt thereof as an active ingredient; and (b) an acrylate-rubber hybrid as an adhesive.
Patent NZ-609954-A (NZ)
Title: A hydroelectric turbine recovery system
Inventor: IVES JAMES
IPC: B63B27/16
Filed: 2011-11-08
Abstract: 609954 A hydroelectric turbine recovery system for recovering a base mounted hydroelectric turbine from a deployment site on the seabed includes a frame 12, 16 having an open mouth 22 allowing the frame to be advanced around the turbine T so that the couplers 32 on the frame can be engaged with the couplers 30 on the base. Once the couplers are engaged the frame, base and turbine can be raised up off the seabed together by cables 14..
Patent NZ-612301-A (NZ)
Title: Water-based drilling fluids containing crosslinked polyacrylic acid
Inventor: BREEDEN DAVID
IPC: F17D1/17
Filed: 2011-01-05
Abstract: The disclosure relates to a water-based drilling fluid comprising a crosslinked polyacrylic acid having a Brookfield viscosity of greater than about 20,000 cP in a 1% dispersion, the pH of the dispersion being greater than or equal to 7.0, wherein the weight average molecular weight of the polyacrylic acid is from about 100,000 to 10 million and further wherein the coefficient of friction of the fluid is less than or equal to 0.15. Also disclosed is a method of drilling a gas or oil well consists of use of a water-based drilling fluids containing high molecular weight crosslinked polyacrylic acid as viscosifying agent, wherein the cross linking agent selected from the group consisting of polyalkenyl ethers and divinyl glycol. The drilling fluid may further contain a lubricant, weighting agent for increasing the density of the drilling fluid, and/or a wetting agent which is a surface active agent or surfactant capable of wetting the solids, as well as laponite clay. The aqueous based drilling fluid exhibits a coefficient of friction which is substantially close to the coefficient of friction of oil based drilling muds. The drilling fluid exhibits stability at well temperatures in excess of 150 ˚C.
Patent NZ-618526-A (NZ)
Title: Amylin peptides and derivatives and uses thereof
Inventor: SUN CHENGZAO
IPC: C07K14/575
Filed: 2012-05-24
Abstract: The disclosure relates to an amylin polypeptide conjugate comprising a polypeptide component linked to a duration enhancing moiety. The duration enhancing moiety is linear polyethylene glycol. The disclosure also relates to the use of such a conjugate for the treatment of eating disorder, insulin resistance, obesity, overweight, abnormal postprandial hyperglycemia, Type I diabetes, Type II diabetes, gestational diabetes, metabolic syndrome, dumping syndrome, hypertension, dyslipidemia, cardiovascular disease, hyperlipidemia, sleep apnea, cancer, pulmonary hypertension, cholescystitis, osteoarthritis, or short bowel syndrome. The polypeptide has the following sequence: Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-Xaa-Ser-Ser-Xaa-Asn-Phe-Xaa- Xaa-Xaa-Xaa-Xaa-Lys-Thr-Xaa-Val-Gly-Lys-Lys-Thr-Tyr-X wherein X and the various Xaa groups are defined in the specification
Patent NZ-622888-A (NZ)
Title: Fishing apparatus and procedures
Inventor: BARNES PAUL
IPC: A01K91/18
Filed: 2011-08-17
Abstract: Disclosed is a slotted reel for carrying and deploying a trotline of a kind that has a plurality of spaced trace lines attached to it, each free end of the trace line attaching to an eye of a formed wire fishing hook , the reel being mounted for rotation to deploy the trot line. The reel comprises a spool with two side flanges where each flange has an internal face facing the spool and an external face remote from the spool, at least one side flange having a plurality of circumferential slots extending inwardly from the outer circumference configured to releasably retain and locate at least the eye on the external face of the least one side flange. Each slot has a width in the circumferential direction greater than the trace line and narrower than the greatest width at the eye of the hook and a thickness greater than the width of the bight of the hook. The slotted reel is mounted to and in a manner able to rotate relative to a mounting member. The mounting member is adapted to be towable by a kontiki or catamaran, is connected so as to be towable by a kontiki or catamaran, or forms part of a kontiki or catamaran, and the mounting member is adapted to be connectable by a mainline to at least one of a (i) retrieval reel and (ii) retrieval and deployment reel. The reel deploys a reel wound trotline and from the slots, reel located fishing hooks. The slotted reel has two side flanges and a spool, at least one of the two side flanges having a plurality of circumferential slots to receive a plurality of hooks located on the trotline in use. The plurality of circumferential slots extends from the outer circumference to the inner circumference of at least one of the two side flanges. The width of each of the plurality of slots is less than the wire gauge of a fishing hook shank. Each of the plurality of slots are longer than the overall length of the fishing hooks. Each of the plurality of slots has a width such that, in use, no part of each hook touches upon any line wound onto the spool of the reel.
Patent NZ-623573-A (NZ)
Title: 4-amino-3-phenylamino-6-phenylpyrazolo[3,4-d] pyrimidine derivatives, manufacture and their use as antiviral active substances
Inventor: WUTZLER PETER
IPC: C07D487/04
Filed: 2012-10-15
Abstract: The disclosure relates to 5-amino-3-pheylamino-6-phenylpyrazolo[3,4-d] pyrimidine derivatives of the general formula (I) or pharmaceutically acceptable salts or prodrugs thereof, wherein at least one hydrogen atom is replaced in at least one of phenyl groups A and B by a substituent RH, which has a Hammett constant σ greater than 0.23. The disclosure further relates to a method of manufacturing these. Corresponding compounds have been found to have surprisingly high activity against viruses, particularly rhinoviruses and picornaviruses. Moreover, the compounds are very well tolerated. For these reasons, the compounds are suited for the treatment of viral infections and as medications.